unknown
Stage
About
Deciphera Pharmaceuticals is a biopharmaceutical company developing targeted cancer therapies, leveraging a proprietary switch-control kinase inhibitor platform to discover and develop small-molecule oncology drugs.
Explore Deciphera Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.